Form D · Biotechnology
PharmaCyte Biotech, Inc.
Las Vegas, NV · CIK 0001157075
Offering snapshot reported Sep 4, 2025 · SEC filing
- Reported sold
- $7M Offering amount: $7M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Aug 17, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 4, 2025 | Initial | $7,000,000 | No comparison | 12 | SEC filing |
| Sep 1, 2021 | Initial | $70,000,000 | No comparison | 19 | SEC filing |
| Jan 19, 2016 | Initial | $1,020,000 | No comparison | 2 | SEC filing |
| Dec 27, 2013 | Initial | $1,136,000 | No comparison | 21 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $560K
- Finders' fees
- $0
- Form D file number
- 021-556587
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| GP NURMENKARI INC. | 000153480 |
Source: Form D, filed Sep 4, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael M. Abecassis | Director |
| Robert Bowker | Director |
| Gerald W Crabtree | Director, Executive |
| Crabtree W. Crabtree | Director, Executive |
| Richard M. Goldfarb | Director |
| Patricia Gruden | Executive |
| Thomas Liquard | Director |
| Timothy Matula | Director |
| Robert F. Ryan | Director |
| Jonathan L. Schechter | Director |
| Joshua N. Silverman | Director, Executive |
| Raymond Cf Tong | Director |
| Carlos Trujillo | Executive |
| Kenneth L. Waggoner | Director, Executive |
| Walker R. Wayne | Director |
| Robert Weinstein | Director |
| Thomas C.K. Yuen | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3960 Howard Hughes Parkway Suite 500
Las Vegas, NV, 89169
Las Vegas, NV, 89169